Viewing Study NCT00015834


Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2025-12-30 @ 10:12 PM
Study NCT ID: NCT00015834
Status: COMPLETED
Last Update Posted: 2013-01-24
First Post: 2001-05-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Blastic Phase Chronic Myelogenous Leukemia View
None Chronic Myelogenous Leukemia, BCR-ABL1 Positive View
None Relapsing Chronic Myelogenous Leukemia View
Keywords: